These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21802305)

  • 1. Pharmacogenetic screening of carbamazepine-induced severe cutaneous allergic reactions.
    Locharernkul C; Shotelersuk V; Hirankarn N
    J Clin Neurosci; 2011 Oct; 18(10):1289-94. PubMed ID: 21802305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the HLA-B*15:02 allele and carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Han individuals of northeastern China.
    He XJ; Jian LY; He XL; Wu Y; Xu YY; Sun XJ; Miao LY; Zhao LM
    Pharmacol Rep; 2013; 65(5):1256-62. PubMed ID: 24399721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population.
    Tassaneeyakul W; Tiamkao S; Jantararoungtong T; Chen P; Lin SY; Chen WH; Konyoung P; Khunarkornsiri U; Auvichayapat N; Pavakul K; Kulkantrakorn K; Choonhakarn C; Phonhiamhan S; Piyatrakul N; Aungaree T; Pongpakdee S; Yodnopaglaw P
    Epilepsia; 2010 May; 51(5):926-30. PubMed ID: 20345939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population.
    Chang CC; Too CL; Murad S; Hussein SH
    Int J Dermatol; 2011 Feb; 50(2):221-4. PubMed ID: 21244392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-B*15:02 association with carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in an Indian population: a pooled-data analysis and meta-analysis.
    Khor AH; Lim KS; Tan CT; Wong SM; Ng CC
    Epilepsia; 2014 Nov; 55(11):e120-4. PubMed ID: 25266342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost minimization of HLA-B*1502 screening before prescribing carbamazepine in Thailand.
    Tiamkao S; Jitpimolmard J; Sawanyawisuth K; Jitpimolmard S
    Int J Clin Pharm; 2013 Aug; 35(4):608-12. PubMed ID: 23649893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
    Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
    J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between HLA and Stevens-Johnson syndrome induced by carbamazepine in Southern Han Chinese: genetic markers besides B*1502?
    Shi YW; Min FL; Qin B; Zou X; Liu XR; Gao MM; Wang Q; Zhou JQ; Liao WP
    Basic Clin Pharmacol Toxicol; 2012 Jul; 111(1):58-64. PubMed ID: 22348435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the HLA-B alleles with carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in the Javanese and Sundanese population of Indonesia: the important role of the HLA-B75 serotype.
    Yuliwulandari R; Kristin E; Prayuni K; Sachrowardi Q; Suyatna FD; Menaldi SL; Wichukchinda N; Mahasirimongkol S; Cavallari LH
    Pharmacogenomics; 2017 Dec; 18(18):1643-1648. PubMed ID: 29053440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese.
    Hung SI; Chung WH; Liu ZS; Chen CH; Hsih MS; Hui RC; Chu CY; Chen YT
    Pharmacogenomics; 2010 Mar; 11(3):349-56. PubMed ID: 20235791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a novel real-time PCR assay for detection of HLA-B*15:02 allele for prevention of carbamazepine - Induced Stevens-Johnson syndrome/Toxic Epidermal Necrolysis in individuals of Asian ancestry.
    Nguyen DV; Vidal C; Chu HC; Do NT; Tran TT; Le HT; Fulton RB; Li J; Fernando SL
    Hum Immunol; 2016 Dec; 77(12):1140-1146. PubMed ID: 27544047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of HLA-B*15:02 in 9 different Chinese ethnics: Implications for carbamazepine related SJS/TEN.
    Ou GJ; Wang J; Ji X; Yu H; Jiang L; Li L; Chen Q; Su PC; Liu Z
    HLA; 2017 Apr; 89(4):225-229. PubMed ID: 28205426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions.
    Amstutz U; Shear NH; Rieder MJ; Hwang S; Fung V; Nakamura H; Connolly MB; Ito S; Carleton BC;
    Epilepsia; 2014 Apr; 55(4):496-506. PubMed ID: 24597466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world efficiency of pharmacogenetic screening for carbamazepine-induced severe cutaneous adverse reactions.
    Chen Z; Liew D; Kwan P
    PLoS One; 2014; 9(5):e96990. PubMed ID: 24806465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain.
    Kulkantrakorn K; Tassaneeyakul W; Tiamkao S; Jantararoungtong T; Prabmechai N; Vannaprasaht S; Chumworathayi P; Chen P; Sritipsukho P
    Pain Pract; 2012 Mar; 12(3):202-8. PubMed ID: 21676164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of HLA-B*1502 and *1511 allele with antiepileptic drug-induced Stevens-Johnson syndrome in central China.
    Sun D; Yu CH; Liu ZS; He XL; Hu JS; Wu GF; Mao B; Wu SH; Xiang HH
    J Huazhong Univ Sci Technolog Med Sci; 2014 Feb; 34(1):146-150. PubMed ID: 24496695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-B*15:21 and carbamazepine-induced Stevens-Johnson syndrome: pooled-data and in silico analysis.
    Jaruthamsophon K; Tipmanee V; Sangiemchoey A; Sukasem C; Limprasert P
    Sci Rep; 2017 Mar; 7():45553. PubMed ID: 28358139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan.
    Chen P; Lin JJ; Lu CS; Ong CT; Hsieh PF; Yang CC; Tai CT; Wu SL; Lu CH; Hsu YC; Yu HY; Ro LS; Lu CT; Chu CC; Tsai JJ; Su YH; Lan SH; Sung SF; Lin SY; Chuang HP; Huang LC; Chen YJ; Tsai PJ; Liao HT; Lin YH; Chen CH; Chung WH; Hung SI; Wu JY; Chang CF; Chen L; Chen YT; Shen CY;
    N Engl J Med; 2011 Mar; 364(12):1126-33. PubMed ID: 21428768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand.
    Rattanavipapong W; Koopitakkajorn T; Praditsitthikorn N; Mahasirimongkol S; Teerawattananon Y
    Epilepsia; 2013 Sep; 54(9):1628-38. PubMed ID: 23895569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.
    Kaniwa N; Saito Y; Aihara M; Matsunaga K; Tohkin M; Kurose K; Furuya H; Takahashi Y; Muramatsu M; Kinoshita S; Abe M; Ikeda H; Kashiwagi M; Song Y; Ueta M; Sotozono C; Ikezawa Z; Hasegawa R;
    Epilepsia; 2010 Dec; 51(12):2461-5. PubMed ID: 21204807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.